Maple Rock Capital Partners Inc. Bausch Health Companies Inc. Transaction History
Maple Rock Capital Partners Inc.
- $2.39 Billion
- Q3 2025
A detailed history of Maple Rock Capital Partners Inc. transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Maple Rock Capital Partners Inc. holds 2,133,887 shares of BHC stock, worth $13.4 Million. This represents 0.58% of its overall portfolio holdings.
Number of Shares
2,133,887
Previous 7,808,487
72.67%
Holding current value
$13.4 Million
Previous $52 Million
73.53%
% of portfolio
0.58%
Previous 2.73%
Shares
5 transactions
Others Institutions Holding BHC
# of Institutions
262Shares Held
207MCall Options Held
2.54MPut Options Held
6.46M-
John Paulson Paulson & Co. Inc. | New York, Ny70.8MShares$444 Million16.32% of portfolio
-
Nomura Holdings Inc Tokyo, M015.7MShares$98.6 Million0.17% of portfolio
-
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A613MShares$81.6 Million0.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.2MShares$76.9 Million0.0% of portfolio
-
Royal Bank Of Canada Toronto, A610.5MShares$66 Million0.01% of portfolio
About Bausch Health Companies Inc.
- Ticker BHC
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 361,728,000
- Market Cap $2.27B
- Description
- Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...